Outcomes of screening mammography performed prior to fertility treatment in women ages 40-49

Published:September 02, 2021DOI:


      • There are currently various recommendations for screening mammography in women 40-49
      • There are no screening recommendations specific for women 40-49 prior to fertility treatment
      • We found 1 screen detected cancer in 118 women (40-49) prior to fertility treatment
      • Screening mammography should be considered prior to fertility treatment



      There are currently various conflicting recommendations for breast cancer screening with mammography in women between ages 40-49. There are no specific guidelines for breast cancer screening in women of this age group prior to assisted reproductive technology (ART) for the treatment of infertility. The purpose of our study was to evaluate outcomes of screening mammography, specifically ordered for the purpose of pre-fertility treatment clearance in women aged 40-49 years old.

      Materials and methods

      This was an IRB approved retrospective study of women aged 40-49 presenting for screening mammography prior to ART between January 2010 and October 2018. Clinical history, imaging, and pathology results were gathered from the electronic medical record. Descriptive statistics were performed.


      Our study cohort consisted of 118 women with a mean age of 42 years (range 40-49). Sixteen of 118 (14%) women were recalled from screening for additional diagnostic work-up. Five of the 16 (31%) were recommended for biopsy (BI-RADS 4 or 5). One of 5 biopsies yielded a malignant result (PPV 20%). Overall cancer detection rate was 0.85% or 8.5 women per 1000 women screened. The single cancer in this cohort was an ER+ PR+ HER2- invasive ductal carcinoma.


      Screening mammography in women 40-49 performed prior to initiation of ART may identify asymptomatic breast malignancy. In accordance with ACR and SBI guidelines to screen women of this age group, women of this age group should undergo screening mammography prior to ART.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. In.

        • Lee C.S.
        • Monticciolo D.L.
        • Moy L.
        Screening guidelines update for average-risk and high-risk women.
        AJR Am J Roentgenol. 2020; 214: 316-323
        • Monticciolo D.L.
        • Newell M.S.
        • Hendrick R.E.
        • et al.
        Breast cancer screening for average-risk women: recommendations from the ACR Commission on breast imaging.
        J Am Coll Radiol. 2017; 14: 1137-1143
      2. SBI Database. In.

        • Siu A.L.
        • Force U.S.P.S.T.
        Screening for breast cancer: U.S. preventive services task force recommendation statement.
        Ann Intern Med. 2016; 164: 279-296
      3. Accessed on 2/19/2021.

      4. Accessed on 2/19/2021.

      5. Accessed on 2/19/2021.

      6. Accessed on 2/19/2021.

        • Paffenbarger Jr., R.S.
        • Kampert J.B.
        • Chang H.G.
        Characteristics that predict risk of breast cancer before and after the menopause.
        Am J Epidemiol. 1980; 112: 258-268
        • Negri E.
        • La Vecchia C.
        • Bruzzi P.
        • et al.
        Risk factors for breast cancer: pooled results from three italian case-control studies.
        Am J Epidemiol. 1988; 128: 1207-1215
        • Helmrich S.P.
        • Shapiro S.
        • Rosenberg L.
        • et al.
        Risk factors for breast cancer.
        Am J Epidemiol. 1983; 117: 35-45
        • MacMahon B.
        • Cole P.
        • Lin T.M.
        • et al.
        Age at first birth and breast cancer risk.
        Bull World Health Organ. 1970; 43: 209-221
        • Ewertz M.
        • Duffy S.W.
        • Adami H.O.
        • et al.
        Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the nordic countries.
        Int J Cancer. 1990; 46: 597-603
        • Bernstein L.
        Epidemiology of endocrine-related risk factors for breast cancer.
        J Mammary Gland Biol Neoplasia. 2002; 7: 3-15
        • Albrektsen G.
        • Heuch I.
        • Hansen S.
        • Kvale G.
        Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects.
        Br J Cancer. 2005; 92: 167-175
        • Layde P.M.
        • Webster L.A.
        • Baughman A.L.
        • Wingo P.A.
        • Rubin G.L.
        • Ory H.W.
        The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. cancer and steroid hormone study group.
        J Clin Epidemiol. 1989; 42: 963-973
        • Price E.R.
        • Keedy A.W.
        • Gidwaney R.
        • Sickles E.A.
        • Joe B.N.
        The potential impact of risk-based screening mammography in women 40–49 years old.
        AJR Am J Roentgenol. 2015; 205: 1360-1364
        • Chen W.Y.
        Exogenous and endogenous hormones and breast cancer.
        Best Pract Res Clin Endocrinol Metab. 2008; 22: 573-585
        • Eliassen A.H.
        • Hankinson S.E.
        Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.
        Adv Exp Med Biol. 2008; 630: 148-165
        • Greenwood H.I.
        • Greenwood E.A.
        • Lee A.Y.
        • Price E.R.
        Outcomes of screening mammography in women less than 40 prior to fertility treatment: a retrospective pilot study.
        Clin Imaging. 2020; 59: 109-113
        • Lehman C.D.
        • Arao R.F.
        • Sprague B.L.
        • et al.
        National Performance Benchmarks for modern screening digital mammography: update from the breast cancer surveillance consortium.
        Radiology. 2017; 283: 49-58
        • Sj B.R.
        Yen and Jaffe’s reproductive endocrinology.
        7th Edition. 2014
        • Clemons M.
        • Goss P.
        Estrogen and the risk of breast cancer.
        N Engl J Med. 2001; 344: 276-285
        • Engmann N.J.
        • Golmakani M.K.
        • Miglioretti D.L.
        • Sprague B.L.
        • Kerlikowske K.
        Breast Cancer Surveillance C. Population-attributable risk proportion of clinical risk factors for breast cancer.
        JAMA Oncol. 2017; 3: 1228-1236
        • Nelson H.D.
        • Zakher B.
        • Cantor A.
        • et al.
        Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.
        Ann Intern Med. 2012; 156: 635-648
        • Hayward J.H.
        • Ray K.M.
        • Wisner D.J.
        • et al.
        Improving screening mammography outcomes through comparison with multiple prior mammograms.
        AJR Am J Roentgenol. 2016; 207: 918-924
        • Yankaskas B.C.
        • May R.C.
        • Matuszewski J.
        • Bowling J.M.
        • Jarman M.P.
        • Schroeder B.F.
        Effect of observing change from comparison mammograms on performance of screening mammography in a large community-based population.
        Radiology. 2011; 261: 762-770
        • Carney P.A.
        • Miglioretti D.L.
        • Yankaskas B.C.
        • et al.
        Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
        Ann Intern Med. 2003; 138: 168-175